{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:38:12Z","timestamp":1792305492302,"version":"4.4.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.tips.2015.04.014","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T20:07:23Z","timestamp":1432584443000},"page":"461-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":969,"title":["Adipokines in health and disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Mathias","family":"Fasshauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2015.04.014_bib0520","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.04.014_bib0525","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1055\/s-2008-1081488","article-title":"Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence","volume":"116","author":"LeRoith","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0530","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2217\/dmt.13.35","article-title":"Importance of adipokines in glucose homeostasis","volume":"3","author":"Bl\u00fcher","year":"2013","journal-title":"Diabetes Manage."},{"key":"10.1016\/j.tips.2015.04.014_bib0535","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","author":"Kl\u00f6ting","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.tips.2015.04.014_bib0540","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","article-title":"Adipose tissue dysfunction contributes to obesity related metabolic diseases","volume":"27","author":"Bl\u00fcher","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0545","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0550","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders","volume":"1\u20132","author":"Lehr","year":"2012","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.tips.2015.04.014_bib0555","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010504","article-title":"Identification and validation of novel adipokines released from primary human adipocytes","volume":"11","author":"Lehr","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.tips.2015.04.014_bib0560","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/13813455.2012.685745","article-title":"Functional annotation of the human fat cell secretome","volume":"118","author":"Dahlman","year":"2012","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.tips.2015.04.014_bib0565","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.metabol.2014.10.016","article-title":"From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century","volume":"64","author":"Bl\u00fcher","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2015.04.014_bib0570","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmet.2014.01.005","article-title":"Adipokines: removing road blocks to obesity and diabetes therapy","volume":"3","author":"Bl\u00fcher","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0575","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4093\/dmj.2012.36.5.317","article-title":"Clinical relevance of adipokines","volume":"36","author":"Bl\u00fcher","year":"2012","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.tips.2015.04.014_bib0580","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0026-0495(71)90084-9","article-title":"Number and size of adipose tissue fat cells in relation to metabolism in human obesity","volume":"20","author":"Bj\u00f6rntorp","year":"1971","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.tips.2015.04.014_bib0585","doi-asserted-by":"crossref","first-page":"E1466","DOI":"10.1210\/jc.2014-1074","article-title":"Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass","volume":"99","author":"Cotillard","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0590","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0595","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kl\u00f6ting","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0600","doi-asserted-by":"crossref","first-page":"E2045","DOI":"10.1210\/jc.2011-1702","article-title":"Regulation of lipolysis in small and large fat cells of the same subject","volume":"96","author":"Laurencikiene","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0605","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00125-014-3214-z","article-title":"The genetics of fat distribution","volume":"57","author":"Schleinitz","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2015.04.014_bib0610","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/oby.20528","article-title":"Fat cell size and adipokine expression in relation to gender, depot, and metabolic risk factors in morbidly obese adolescents","volume":"22","author":"Zhang","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.tips.2015.04.014_bib0615","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kl\u00f6ting","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0620","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.metabol.2011.10.008","article-title":"Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity","volume":"61","author":"Chakaroun","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2015.04.014_bib0625","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db08-1147","article-title":"Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue","volume":"58","author":"Youn","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0630","doi-asserted-by":"crossref","first-page":"e99785","DOI":"10.1371\/journal.pone.0099785","article-title":"Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation","volume":"9","author":"Flehmig","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2015.04.014_bib0635","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1126\/science.3299705","article-title":"Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve","volume":"237","author":"Cook","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.tips.2015.04.014_bib0640","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.3299706","article-title":"Severely impaired adipsin expression in genetic and acquired obesity","volume":"237","author":"Flier","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.tips.2015.04.014_bib0645","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","article-title":"Adipsin is an adipokine that improves \u03b2 cell function in diabetes","volume":"158","author":"Lo","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tips.2015.04.014_bib0650","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tips.2015.04.014_bib0655","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.04.014_bib0660","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib0665","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.metabol.2012.04.013","article-title":"Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials","volume":"61","author":"Foo","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2015.04.014_bib0670","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","article-title":"Leptin in human physiology and pathophysiology","volume":"301","author":"Mantzoros","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0675","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S2213-8587(13)70176-1","article-title":"Adipokines in gestational diabetes","volume":"2","author":"Fasshauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tips.2015.04.014_bib0680","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2015.04.014_bib0685","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jcem.85.11.6955","article-title":"Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men","volume":"85","author":"Hukshorn","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0690","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2015.04.014_bib0695","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.tips.2015.04.014_bib0700","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tips.2015.04.014_bib0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","article-title":"Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives","volume":"18","author":"Dalamaga","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0710","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molmet.2013.04.001","article-title":"Adiponectin, driver or passenger on the road to insulin sensitivity?","volume":"2","author":"Ye","year":"2013","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0715","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.04.014_bib0720","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.04.014_bib0725","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2015.04.014_bib0730","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2015.04.014_bib0735","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00125-008-0944-9","article-title":"Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration","volume":"51","author":"Okamoto","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2015.04.014_bib0740","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.04.014_bib0745","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(13)70120-7","article-title":"Adiponectin and its receptors: implications for obesity-associated diseases and longevity","volume":"2","author":"Kadowaki","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tips.2015.04.014_bib0750","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.metabol.2014.05.001","article-title":"Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: a systematic review and meta-analysis","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2015.04.014_bib0755","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amjcard.2013.09.027","article-title":"Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults >\/=65 years of age (from the Cardiovascular Health study)","volume":"113","author":"Karas","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tips.2015.04.014_bib0760","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjcard.2011.03.053","article-title":"Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study)","volume":"108","author":"Cote","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tips.2015.04.014_bib0765","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/dyt087","article-title":"Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis","volume":"42","author":"Sook Lee","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.tips.2015.04.014_bib0770","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2015.04.014_bib0775","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tips.2015.04.014_bib0780","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0785","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2015.04.014_bib0790","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1\u03b1 and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.tips.2015.04.014_bib0795","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800.2011.558550","article-title":"Serum FGF-21 levels in type 2 diabetic patients","volume":"36","author":"Cheng","year":"2011","journal-title":"Endocr. Res."},{"key":"10.1016\/j.tips.2015.04.014_bib0800","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","article-title":"Inventing new medicines: the FGF21 story","volume":"3","author":"Kharitonenkov","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0805","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma","volume":"109","author":"Wei","year":"2012","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2015.04.014_bib0810","doi-asserted-by":"crossref","first-page":"e00065","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor\u201321, extends lifespan in mice","volume":"1","author":"Zhang","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.tips.2015.04.014_bib0815","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature11943","article-title":"Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat","volume":"495","author":"Schulz","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.04.014_bib0820","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cytogfr.2009.10.019","article-title":"Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism","volume":"20","author":"Schulz","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.tips.2015.04.014_bib0825","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature07221","article-title":"New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure","volume":"454","author":"Tseng","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.04.014_bib0830","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1096\/fj.11-199067","article-title":"Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway","volume":"26","author":"Townsend","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2015.04.014_bib0835","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.spinee.2007.03.012","article-title":"The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study","volume":"8","author":"Vaccaro","year":"2008","journal-title":"Spine J."},{"key":"10.1016\/j.tips.2015.04.014_bib0840","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/db11-1419","article-title":"The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans","volume":"61","author":"Gustafson","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0845","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/db14-1127","article-title":"BMP4 and BMP antagonists regulate human white and beige adipogenesis","volume":"64","author":"Gustafson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0850","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib0855","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib0860","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib0865","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2015.04.014_bib0870","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0875","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-011-9572-0","article-title":"Vaspin in obesity and diabetes: pathophysiological and clinical significance","volume":"41","author":"Bl\u00fcher","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.tips.2015.04.014_bib0880","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00125-011-2137-1","article-title":"Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects","volume":"54","author":"Kl\u00f6ting","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2015.04.014_bib0885","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00018-013-1258-8","article-title":"Vaspin inhibits kallikrein 7 by serpin mechanism","volume":"70","author":"Heiker","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2015.04.014_bib0890","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2015.04.014_bib0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-011-9507-9","article-title":"Apelin, diabetes, and obesity","volume":"40","author":"Castan-Laurell","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.tips.2015.04.014_bib0900","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2015.04.014_bib0905","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/en.2010-0576","article-title":"Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms","volume":"152","author":"Yue","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2015.04.014_bib0910","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1389450115666141128120053","article-title":"Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases","volume":"16","author":"Cao","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.tips.2015.04.014_bib0915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S095442241400002X","article-title":"Regulation of adipocyte lipolysis","volume":"27","author":"Fr\u00fchbeck","year":"2014","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.tips.2015.04.014_bib0920","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000348667","article-title":"Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity","volume":"6","author":"Krist","year":"2013","journal-title":"Obes. Facts"},{"key":"10.1016\/j.tips.2015.04.014_bib0925","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2005.05.004","article-title":"The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice","volume":"131","author":"Sorhede Winzell","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.tips.2015.04.014_bib0930","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0935","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib0940","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2010.11.002","article-title":"Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications","volume":"124","author":"Nauck","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib0945","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.2337\/db13-0822","article-title":"Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls","volume":"62","author":"Drucker","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0950","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tips.2015.04.014_bib0955","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.04.014_bib0960","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/dc13-0496","article-title":"Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro","volume":"36","author":"Sell","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tips.2015.04.014_bib0965","first-page":"185","article-title":"Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose","volume":"7","author":"Das","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.tips.2015.04.014_bib0970","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.febslet.2014.08.029","article-title":"Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells","volume":"588","author":"R\u00f6hrborn","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2015.04.014_bib0975","doi-asserted-by":"crossref","first-page":"T37","DOI":"10.1530\/JOE-12-0278","article-title":"The role of adipokines in \u03b2-cell failure of type 2 diabetes","volume":"216","author":"Dunmore","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tips.2015.04.014_bib0980","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-alpha and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2015.04.014_bib0985","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tips.2015.04.014_bib0990","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.04.014_bib0995","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.tips.2015.04.014_bib1000","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1210\/en.2007-0978","article-title":"Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance","volume":"149","author":"Liang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2015.04.014_bib1005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3899\/jrheum.131150","article-title":"Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-\u03b1 treatment","volume":"41","author":"Hmamouchi","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.tips.2015.04.014_bib1010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2119\/molmed.2010.00221","article-title":"Chronic TNF-alpha neutralization does not improve insulin resistance or endothelial function in \u2018healthy\u2019 men with metabolic syndrome","volume":"17","author":"Wascher","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib1015","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2015.04.014_bib1020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-065X.2012.01145.x","article-title":"Inflammation links excess fat to insulin resistance: the role of the interleukin\u20131 family","volume":"249","author":"Tack","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tips.2015.04.014_bib1025","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00430.2013","article-title":"Interleukin-1\u03b2 mediates macrophage-induced impairment of insulin signaling in human primary adipocytes","volume":"307","author":"Gao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2015.04.014_bib1030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2337\/db13-1511","article-title":"T cell-derived IL-22 amplifies IL-1\u03b2-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes","volume":"63","author":"Dalmas","year":"2014","journal-title":"Diabetes"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T10:32:35Z","timestamp":1566729155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614715000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0165614715000905"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2015.04.014","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipokines in health and disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2015.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}